Cite

HARVARD Citation

    Leiter, L. et al. (2016). Frequency of cancer events with saxagliptin in the SAVOR‐TIMI 53 trial. Diabetes, obesity & metabolism. 18 (2), pp. 186-190. [Online]. 
  
Back to record